ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Raymond Cartier
Paolo Panisi
Claude M. Grondin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrade, I. G.
Right arrow Articles by Grondin, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrade, I. G.
Right arrow Articles by Grondin, C. M.

Ann Thorac Surg 1987;44:607-613
© 1987 The Society of Thoracic Surgeons


Articles

Factors Influencing Early and Late Survival in Patients with Combined Mitral Valve Replacement and Myocardial Revascularization and in Those with Isolated Replacement

Ignacio Garcia Andrade, M.D., Raymond Cartier, M.D., Paolo Panisi, M.D., Kamel Ennabli, M.D., Claude M. Grondin, M.D.*

From the Department of Surgery, Montreal Heart Institute, Montreal, Que, Canada

Accepted for publication June 8, 1987.

* Address reprint requests to Dr. Grondin, Department of Surgery, Montreal Heart Institute, 5000 Belanger St, Montreal, Que, Canada HIT 1C8

During a 5 1/2-year period, 251 patients underwent mitral valve replacement (MVR) at our institution: 76 had combined MVR and coronary artery bypass grafting (CABG), and 175 without major coronary artery disease (CAD) had isolated MVR. In-hospital mortality for MVR + CABG was 13.2% (10/76); it was 8.6% (6/70) when patients with preoperative mechanical support were excluded, 7.9% (5/63) for elective operations, and 8.2% (5/61) for nonischemic mitral disease. Overall, in-hospital mortality for isolated MVR was 6.3% (11/175); it was 4.4% (7/161) excluding patients requiring mechanical support and 3.1% (5/157) for elective operations.

Of a host of clinical characteristics in patients with MVR + CABG, few were found to influence in-hospital mortality: age greater than 60 years, degree of incapacitation (New York Heart Association Functional Class IV), previous history of myocardial infarction or congestive heart failure, cardiac enlargement (cardiothoracic index greater than 50%), and ischemic mitral disease (33.3% in-hospital mortality; p < 0.05). Of the invasive variables, only one influenced in-hospital mortality: wall motion score greater than 10 (31.6% in-hospital mortality; p < 0.01). Of the operative variables studied, the number of grafts (3 or more: 33.3% in-hospital mortality; p < 0.05), the need for mechanical support (47.4% in-hospital mortality; p < 0.0001), and emergency operation (38.5% in-hospital mortality; p < 0.005) had a significant effect on mortality. The type of mitral lesion, the type of prosthesis, the extent of CAD or the completeness of revascularization, the presence of pulmonary hypertension, and atrial fibrillation appeared to have no influence.

Survival at 6 years was 83 ± 5% for patients having MVR + CABG and 89 ± 2% for those having isolated MVR (p < 0.03). Of the following variables—ejection fraction, extent of CAD, completeness of revascularization, etiology of lesion, and wall motion score—only the last strongly influenced late survival in patients with MVR + CABG.

In summary, in-hospital mortality is higher among patients having MVR + CABG, especially if urgent operation or mechanical support is needed and multiple bypass grafts are performed. Age and cardiac enlargement also play a role. Once CAD is corrected, that is, when most— but not necessarily all—diseased arteries are bypassed, overall survival does not differ from that of patients with isolated MVR and no major CAD. The single most important variable for early and late survival in MVR + CABG appears to be wall motion score at cineventriculography.




This article has been cited by other articles:


Home page
Card Surg AdultHome page
M. LeBoutillier III and V. J. DiSesa
Valvular and Ischemic Heart Disease
, January 1, 2008; 3(2008): 1175 - 1192.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. F. Ibrahim, D. Paparella, J. Ivanov, M. R. Buchanan, and S. J. Brister
Gender-related differences in morbidity and mortality during combined valve and coronary surgery
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 959 - 964.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
M. LeBoutillier III and V. J. DiSesa
Valvular and Ischemic Heart Disease
, January 1, 2003; 2(2003): 1057 - 1074.
[Full Text]


Home page
Eur J Cardiothorac SurgHome page
C. M. de Almeida Brandao, P. M. A. Pomerantzeff, L. R. Souza, F. Tarasoutchi, M. Grimberg, J. A. F. Ramires, and S. Almeida de Oliveira
Multivariate analysis of risk factors for hospital mortality in valvular reoperations for prosthetic valve dysfunction
Eur J Cardiothorac Surg, December 1, 2002; 22(6): 922 - 926.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
R. G. Seipelt, F. A. Schoendube, J. F. Vazquez-Jimenez, H. Doerge, M. Voss, and B. J. Messmer
Combined mitral valve and coronary artery surgery: ischemic versus non-ischemic mitral valve disease
Eur J Cardiothorac Surg, August 1, 2001; 20(2): 270 - 275.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. L. Hannan, M. J. Racz, R. H. Jones, J. P. Gold, T. J. Ryan, J.-P. Hafner, and O. W. Isom
Predictors of mortality for patients undergoing cardiac valve replacements in New York State
Ann. Thorac. Surg., October 1, 2000; 70(4): 1212 - 1218.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. H. Thourani, W. S. Weintraub, J. M. Craver, E. L. Jones, J. P. Gott, W. M. Brown III, J. D. Puskas, and R. A. Guyton
Influence of concomitant CABG and urgent/emergent status on mitral valve replacement surgery
Ann. Thorac. Surg., September 1, 2000; 70(3): 778 - 783.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W.R. E. Jamieson, F. H. Edwards, M. Schwartz, J. W. Bero, R. E. Clark, and F. L. Grover
Risk stratification for cardiac valve replacement. National Cardiac Surgery Database
Ann. Thorac. Surg., April 1, 1999; 67(4): 943 - 951.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovascular and Thoracic AnnalsHome page
B. Yamak, A. T. Ulus, S. F. Katircioglu, B. Mavitas, A. Saritas, O. Tasdemir, and K. Bayazit
Surgery for Combined Rheumatic Valve and Coronary Artery Disease
Asian Cardiovascular and Thoracic Annals, March 1, 1999; 7(1): 33 - 36.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. J. Flameng, P. Herijgers, J. Szecsi, P. T. Sergeant, W. J. Daenen, and I. Scheys
Determinants of Early and Late Results of Combined Valve Operations and Coronary Artery Bypass Grafting
Ann. Thorac. Surg., February 1, 1996; 61(2): 621 - 628.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. L. Jones, W. S. Weintraub, J. M. Craver, R. A. Guyton, and Y. Shen
Interaction of age and coronary disease after valve replacement: Implications for valve selection
Ann. Thorac. Surg., August 1, 1994; 58(2): 378 - 385.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The Society of Thoracic Surgeons.